Merck & Co. DEF 14A: Executive Compensation Details
Ticker: MRK · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 310158
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: MRK
TL;DR
Merck's proxy statement is out, detailing exec pay for 2024. Check it for compensation specifics.
AI Summary
Merck & Co., Inc. filed its DEF 14A on April 9, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on named executive officers such as Mr. Frazier and details compensation components like equity awards and pension benefits. The company's principal executive offices are located at 126 East Lincoln Avenue, Rahway, NJ.
Why It Matters
This filing provides shareholders with crucial information regarding how top executives at Merck are compensated, influencing company strategy and investor confidence.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information on executive compensation and corporate governance, not indicating new or unusual risks.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for compensation details)
- 1231 — Fiscal Year End (Standard fiscal year end date)
Key Players & Entities
- Merck & Co., Inc. (company) — Filer
- Mr. Frazier (person) — Named Executive Officer
- 0001193125-25-076859 (filing_id) — Accession Number
- 20250409 (date) — Filing Date
- 20250527 (date) — Period of Report
- 0000310158 (cik) — Central Index Key
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting of stockholders, including details on director and executive compensation, corporate governance, and voting matters.
Who are the key individuals mentioned in relation to compensation data?
The filing references specific members such as 'mrk:LiMember', 'mrk:DelucaMember', 'mrk:LarsonMember', 'mrk:DavisMember', 'mrk:LitchfieldMember', and 'mrk:Mr.FrazierMember', indicating they are part of the compensation discussion.
What is the filing date of this document?
This DEF 14A filing was made on April 9, 2025.
What is the period of report for this filing?
The period of report for this filing is May 27, 2025.
Where are Merck & Co., Inc.'s principal executive offices located?
Merck & Co., Inc.'s principal executive offices are located at 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 by Mr. Frazier regarding Merck & Co., Inc. (MRK).